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Intranasal sedation using ketamine and
midazolam for pediatric dental treatment
(NASO): study protocol for a randomized
controlled trial
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Abstract
Background: Uncooperative children may need to receive dental treatment under sedation, which is indicated
when nonpharmacological behavior guidance is unsuccessful. There are randomized controlled trials (RCTs)
comparing different sedative protocols for dental procedures; however, the evidence for superiority of one form
over another is weak. The primary aim of this study is to investigate the efficacy of intranasally administered
ketamine plus midazolam for the dental treatment of children.
Methods: We have designed a three-armed, parallel RCT to assess intranasal sedation using ketamine/midazolam in
terms of the following measures: efficacy, safety, and cost-effectiveness. Two- to 6-year-old healthy children, referred
for dental treatment in a dental sedation center in Brazil due to uncooperative behavior and requiring restorative
dental procedures, will be recruited. Each child will be randomly assigned to one of the three groups: A – Intranasal
administration of ketamine (4.0 mg/kg, maximum 100 mg) and midazolam (0.2 mg/kg, maximum 5.0 mg); B – Oral
administration of ketamine (4.0 mg/kg, maximum 100 mg) and midazolam (0.5 mg/kg, maximum 20 mg); and C –
Oral administration of midazolam (1.0 mg/kg, maximum 20 mg). The primary outcome is the child’s behavior
assessed through an observational scale using digital videos of the restorative dental treatment under sedation. The
secondary outcomes are as follows: acceptance of sedative administration; memory of intraoperative events; the
child’s stress; adverse events; the child’s pain during the procedure; the parent’s, dentists’, and child’s perceptions of
sedation; and economic analysis. Measures will be taken at baseline and drug administration and during and after
the dental procedure. The necessary sample size was estimated to be 84 children after a blinded interim analysis of
the first 30 cases.
Discussion: This study will provide data that can substantially add to science and pediatric dentistry as it examines
the effect of sedative regimes from different perspectives (outcomes).
Trial registration: ClinicalTrials.gov, identifier: NCT02447289. Registered on 11 May 2015, named “Midazolam and
Ketamine Effect Administered Through the Nose for Sedation of Children for Dental Treatment (NASO).”
Keywords: Dental care for children, Conscious sedation, Child behavior, Midazolam, Ketamine, Administration
intranasal, Pain assessment, Amnesia, Stress, Physiological, Patient satisfaction
* Correspondence: lsucasas@ufg.br
5Department of Oral Health, FO/UFG, Goiânia, GO 74605-220, Brazil
7Faculdade de Odontologia, Universidade Federal de Goiás, Primeira Avenida,
Setor Universitário, CEP: 74605-220 Goiânia, Goiás, Brazil
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Gomes et al. Trials  (2017) 18:172 
DOI 10.1186/s13063-017-1919-2
Background
Preschool children may present dental behavior manage-
ment problems (DBMP) and, therefore, refuse routine
dental treatment due to several factors such as dental fear
[1] and personal temperament [2]. Consequently, that
group of patients are more likely to be referred for a den-
tal sedation appointment [3–5] or general anesthesia [6].
Conscious sedation is a form of advanced behavior
guidance technique, which is indicated for uncooperative
or fearful/anxious children due to a lack of psycho-
logical, emotional or mental maturity or a physical or
medical disability [7]. This pharmacological approach
aims to enhance the patient’s physical comfort and safety
and to control anxiety and behavior, as well as to allow
for the completion of the procedure [7]. Several random-
ized controlled trials (RCTs) have been published dem-
onstrating the efficacy of conscious sedation in pediatric
dentistry, but evidence on this topic, though still weak,
points to the efficacy of midazolam [8].
Our research group has conducted investigations aim-
ing to find the most beneficial sedative protocol for
young children undergoing dental treatment. In one of
these studies, children under 36 months displayed more
cooperative behavior after oral administration of mid-
azolam (0.5 mg/kg) plus ketamine (3.0 mg/kg) compared
to either oral midazolam (1.0 mg/kg) or no sedative
agent (placebo) [9]. Therefore, we concluded that, for
young children, it might be advisable to combine keta-
mine with midazolam to provide better results in
pediatric dental sedation.
The research concerning intranasal procedural sed-
ation has been highlighted due to its faster onset of ac-
tion and recovery time and less discomfort and cost
compared to other routes of sedative administration
[10]. In line with the aforementioned efficacy of orally
administered ketamine/midazolam [9], we did a search
in PubMed and found only one study in pediatric dentis-
try that used intranasally administered ketamine plus
midazolam [11]. Based on a crossover design with 45
children aged 2–6 years, that study [11] revealed high
success rates for intranasal sedation as follows: ketamine
(6.0 mg/kg) – 89%; midazolam and ketamine (0.2 mg/kg
and 4.0 mg/kg) – 84%; and midazolam (0.3 mg/kg) –
69%. In the medical pediatric field, the combination of
ketamine and midazolam to perform gastric aspirates
has been successful [12]. However, there is a lack of
RCTs investigating the intranasal route to deliver
ketamine-midazolam in procedural sedation.
Pediatric dental sedation outcomes have primarily
been assessed through children’s behavior during the
procedure, but the assessment of other “core variables,”
including baseline anxiety, completion of treatment, and
patient satisfaction or preference, is advisable [8]. How-
ever, there are other assessments that can be beneficial
for the evaluation of sedation success if performed using
a systematic method. Given the lack of evidence on
which a sedative regimen is more effective for pediatric
dental patients and the requirement for more well-
designed studies [8], the development of a RCT on
pediatric dental sedation comprising multiple assess-
ments is timely. For the purpose of this study, multiple
assessments are defined as specified in Table 1.
Thus, the overall aim of this paper is to present the
methodology of a RCT to investigate the efficacy of
intranasally administered ketamine plus midazolam
compared to the same drugs administered orally and to
Table 1 Definitions of the multiple outcomes included in this study protocol
Outcome Definition Instrument/tool
Children’s behavior toward
dental treatment
Crying and movement during the dental sedation Ohio State University Behavioral Rating Scale (OSUBRS) [13]
Children’s pain during the
dental sedation
Facial expression of pain during the dental procedure
under sedation
The Faces, Legs, Activity, Cry, Consolability Pain Assessment
Tool (FLACC) [14]
Children’s acceptance of the
sedative administration
Crying, movement and pain during the sedative
administration through the oral and intranasal routes
OSUBRS [13] and FLACC [14]
Memory of intraoperative
procedures
Recall/recognition of pictures and events that occurred
throughout dental appointment
Three-stage procedure [15] on the treatment day and
semistructured interview with parents on the next day
Children’s, parents’, and
dentists’ stress
Physiological response to stress during dental treatment
under conscious sedation
Cortisol levels in saliva of all participants and self-report
from parents and dentists
Children’s perceptions of
sedation
How do the children perceive the dental sedation
procedure?
Semistructured qualitative interview 1 week later
Parents’ and dentists’
perceptions of children’s
sedation
If parents and dentists are satisfied, feel stress or think
that children had pain during the dental sedation
Questions answered through a Visual Analog Scale (VAS)
Adverse events Unexpected and undesirable response to sedatives
that threaten or cause patient injury or discomfort [16]
World SIVA International Sedation Task Force Tool [16]
Economic analysis Cost-effectiveness Decision tree [17]
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a control sedative (orally administered midazolam only).
The specific aims are to investigate the following out-
comes: the children’s behavior during the dental sedation
procedure (primary outcome); the acceptance of the
sedative administration; the pain and memory of intra-
operative events; the children’s, parents’, and dentists’
perceptions of sedation and stress; the occurrence of ad-
verse events during and after sedative administration;
and the economic analysis of the three sedative regimes.
The primary hypothesis is that the combination of
ketamine and midazolam, administered intranasally, is
more efficacious when compared to the same combin-
ation or midazolam only administered orally as mea-
sured by the child’s behavior according to the Ohio State
University Behavioral Rating Scale (OSUBRS). Sedation
is considered efficacious if quiet behavior (OSUBRS
score 1) occurs at or above 60% of the session length.
Methods/design
Ethical considerations
Ethical approval was granted by the Research Ethics Com-
mittee of the Universidade Federal de Goiás (UFG), Brazil
(protocol #857.066, 12 November 2014). This study is
registered in the Clinical Trials database (http://clinical-
trials.gov/ct2/show/NCT02447289, NCT02447289 (see
Additional file 1). If changes are required at any stage of
the study, the alterations will be recorded in the protocol
in the Clinical Trials database and reported to the Ethics
Committee. Informed consent will be sought from the
parents of the children. The process of obtaining in-
formed consent will consist of the reading aloud of
consent by a research participant sitting next to at
least one of the child’s parents; after reading the Con-
sent Form (Additional file 2), the researcher will en-
courage the parent to ask any remaining questions;
when the parent feels able to make a decision (in the
same or in another session), they will be asked about
the decision to participate. As there are data that will be
collected from parents and dentists, they will also be in-
vited to participate and, if in agreement, they will sign a
specific Consent Form (Additional file 2). Participants can
withdraw from the study at any time, and withdrawal from
the study will not affect their dental care in the dental
school. The children who participate in the study who
present more dental treatment needs, or those whose par-
ents refuse to participate in the study, will also be treated
in the dental school. All collected data (questionnaire an-
swers, scales, digital videos, saliva, etc.) involving children,
parents, and dentists will be kept confidential by the team,
which will adopt password-encrypted access to databases
and the use of code instead of the participant’s name. The
results, whether favorable or not, will be made public
through the presentation of abstracts at events and the
publication of articles.
Study design and setting
This study is a three-armed, triple-blind RCT with a par-
allel design performed at the UFG Dental School in the
Dental Sedation Center Núcleo de Estudos em Sedação
Odontológica (NESO) (translation: Study Center in Den-
tal Sedation). NESO is the only public outpatient dental
sedation center available in central Brazil and is com-
prised of a multidisciplinary team that provides dental
sedation for referred people, mostly children. NESO fol-
lows sedative routines recommended by international
guidelines [18]. Each member of the research team is
trained to perform a different childcare role under sed-
ation, and the team consists of pediatric dentists, a
pediatrician, an anesthesiologist, a psychologist, general
dentists, and graduate and undergraduate students.
The development of this study is shown in a flow dia-
gram (Figs. 1 and 2) and will be carried out according to
a timeline (Fig. 3). This flow is detailed in the subse-
quent subheadings and is in agreement with the “Stand-
ard Protocol Items: Recommendations for Interventional
Trials” (SPIRIT) Statement (Additional file 3) [19].
Members of the research team were trained for each
step of the study.
A pilot study was performed in December 2014 to
rehearse the recruitment, randomization, allocation,
documentation, and sedation procedures according to
the already planned methods. In this phase, nine patients
were recruited, and three received dental treatment with
sedation; however, they will not be included in the group
of participants of the final sample.
Participants and recruitment
Healthy preschool children, referred for dental treatment
under sedation at NESO due to uncooperative behavior
requiring dental restorative procedures, will be assessed
for the eligibility criteria in a recruitment appointment.
The inclusion criteria for the children are as follows:
aged 2–6 years old with a physical status categorized as
ASA I (healthy) or II (mild systemic disease) [20] and lit-
tle risk of airway obstruction [20] (Mallampati I and II
and tonsil hypertrophy occupying less than 50% of the
oropharynx) [21], no medical history of neurological or
cognitive alterations, absence of facial deformities, were
born at term, do not use medications that may impair
cognitive functions, and have at least two decayed teeth
without pulp involvement, requiring dental restoration
under local anesthesia and rubber dam. If there are sys-
temic alterations that contraindicate sedation during the
research, treatment will be postponed or interrupted.
The exclusion criterion is related to the child’s favor-
able behavior in a dental restorative session without
sedation conducted by the pediatric dentist assisted by
other members of the research team. Therefore, if a
child shows positive behavior (acceptance of treatment,
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is willing to collaborate with the dentist and follow-up
on the dentist’s recommendations) [22] or definitely
positive behavior (interacts with the dentist, interested
in the dental procedure and has a fun time) [22] in that
session, they will be excluded from the study. This cri-
terion was proposed to avoid inclusion of cooperative
children in the sedation session, thereby introducing bias
in the final results.
Randomization and blinding
One blinded researcher (LRC) will carry out the
randomization using the online calculator (http://
www.randomization.com) that will determine the inter-
vention group for each participant, using blocks of 15
cases. An allocation concealment strategy is achieved
with a specific code enclosed in sequentially numbered,
opaque, sealed envelopes to conceal the sequence until
the intervention is assigned; numbers N1…N84 are writ-
ten in the envelopes in advance, and the envelopes are
opened sequentially, only after the participant’s name is
written on the appropriate envelope.
All participants, as well as the researchers who
analyze the measures throughout the data collection,
will be blinded to the intervention group. Only the
pediatrician (PSC) and the anesthesiologist (JSF) will
be aware of the group allocation to be able to take
urgent measures in case of adverse events. The statis-
tician will also be blinded during the analysis, and
only after data collection is completed and the initial
analyses are performed, the randomization code will
be broken to input the group allocation.
Interventions
Children who are included in the study will be ran-
domly assigned to one of the three comparison
groups (Table 2). The administration of sedatives fol-
lows a strict sequence and time interval (Fig. 4), and
no supplemental nitrous oxide/oxygen will be used.
The sedative administration will be as follows:
1. The anesthesiologist will confirm the child’s
health status and fasting time; if there is any
Fig. 1 Flow diagram of the intranasal sedation using ketamine and midazolam for pediatric dental treatment (NASO) study protocol
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problem, the procedure will be re-scheduled and
postponed for at least 1 week
2. The child and a parent will be positioned in a dental
chair in the sedative delivery room
3. The administration of the sedative agent will be
filmed with one action camera mounted on the
anesthesiologist’s head while an observer records
the heart rate and oxygen saturation during
administration
4. The anesthesiologist will first administer the
syrups (midazolam/ketamine, midazolam or
placebo) per the oral route (Fig. 4); if the child
does not spontaneously accept the syrups, a
mouth prop and active physical restraint by the
parent will be used
5. The anesthesiologist will administer the sedatives or
placebo per the intranasal route (Fig. 4), starting
with ketamine dispensed in an insulin syringe and an
atomizer (LMA MAD Nasal, Teleflex, Fort Worth,
TX, USA) with a maximum dose of 0.5 mL per
nares and followed by midazolam
6. The child will be allocated to the intervention group
(A, B or C) according to the previous randomization
(Table 2)
Because the participants and research team, other than
the anesthesiologist and pediatrician, are blinded to the
intervention, the oral and intranasally administered pla-
cebos will be prepared as magistral formulations with
the same characteristics as those of the active drug.
Fig. 2 A closer view of the children’s participation flow in the intranasal sedation using ketamine and midazolam for pediatric dental treatment
(NASO) study protocol
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Medical and dental examination
The medical examination will be performed to confirm
the health history and obtain vital signs at baseline. For
the standard dental examination, a dentist will perform a
dental prophylaxis procedure and intraoral examination,
while another dentist or dental student records the
dental needs in a specific form according to the recom-
mendations from the World Health Organization [23].
During this procedure, nonpharmacological behavior
management methods will be used as necessary. If the
child is cooperative (positive or definitely positive behav-
ior according to the Frankl scale [22]), they will be
scheduled for one dental session treatment without sed-
ation; otherwise, they will go directly to a dental session
treatment under sedation.
Dental session treatment with or without sedation
During the dental examination, the child may present
positive or negative behavior. If positive, the child will be
scheduled for a restorative dental treatment session
TIMEPOINT
June 
2015
2nd semester
2015
1st semester 
2016
2nd semester
2016
1st semester
2017
ENROLMENT:
Eligibility screen
Informed consent
Dental consultations
Allocation
INTERVENTIONS:
Group A
Group B
Group C
ASSESSMENTS:
Primary outcome
Secondary outcomes 
pain, acceptance, 
memory, stress, 
perceptions, adverse 
events and
economic analysis
Fig. 3 Schedule of the enrollment, interventions, and assessments
Table 2 Interventions according to groups
Group Type Intranasal Oral
A Experimental Ketamine (4.0 mg/kg, maximum 100 mg)a +midazolam
(0.2 mg/kg, maximum 5.0 mg)b
Placebo
B Drug route comparison Placebo Ketamine (4.0 mg/kg, maximum 100 mg)a +midazolam
(0.5 mg/kg, maximum 20 mg)c
C Control Placebo Midazolam (1.0 mg/kg, maximum 20 mg)c
aInjectable solution in a concentration of 50.0 mg/mL (Ketamin S, Cristalia, Sao Paulo, Brazil
bInjectable solution in a concentration of 5.0 mg/mL (Dormire solução injetável, Cristalia, Sao Paulo, Brazil)
cOral solution in a concentration of 2.0 mg/mL (Dormire solução oral, Cristalia, Sao Paulo, Brazil)
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without sedation to confirm the need for sedation. If the
behavior is not positive, the child will be scheduled
directly for pediatric dental sedation. Both restorative
treatment sessions will be as similar as possible and are
detailed below. A pediatric dentist will perform one tooth
restoration under local anesthesia using a rubber dam.
Nonpharmacological behavior management methods will
be used as necessary.
The procedures for data collection will be carried out
according to the following steps:
Saliva sample collection
Saliva samples will be collected from the child, pediatric
dentist, and parent at the following times:
1. Just upon arrival at the dental school
2. For the sedation session only, 25 min after the
administration of the last sedative from the child
only
3. Twenty-five minutes after local anesthesia
4. Twenty-five minutes after the end of the procedure
The collection time is 25 min after the stressful stimu-
lus because of the time required for the cortisol level to
reach its peak in the saliva [24].
The collection of saliva samples will be conducted using
Salivette tubes (Sarstedt Inc., Nümbrecht, Alemanha) with
gloved hands. A cotton roll will be placed in the child’s
mouth for a period of 1 to 2 min, until it is soaked with
saliva. Then, the cotton will be returned to the tube and
centrifuged. The saliva sample will then be kept frozen
until the analysis procedure.
Memory assessment
1. Before starting the dental procedure, two pictures
will be shown to the child through a tablet with an
interval of 4 min. The child must verbally identify
the image. If they do not identify the image or
cannot name the item displayed, the researcher will
speak the name and ask the child to repeat it (phase
1 – encoding phase)
2. For the sedation session only, the two different figures
will be shown 1 and 5 min after the administration
of the last sedative (minute 13)
3. Immediately before the dental prophylaxis
procedure, the dentist will show an animal toy for
the child and ask them to verbally identify it (“There
is a bug here in your tooth. Do you know what it
looks like? This here. What is this?”)
4. Immediately before discharge, the dentist will ask
the child to speak the names of all of the items in
phase 1 (recall task) and identify the pictures
presented in the encoding phase among four figures
– two target and two distractor pictures (recognition
task). Similarly, the child will be asked which animal
toy was shown before the dental prophylaxis
procedure (phase 2 – recognition and recall tasks)
The times of the presentation of the pictures in this
three-stages procedure (encoding, retention interval and
test phase) [15] were chosen based on another study in
pediatric dentistry [25].
Dental restorative procedure
1. One parent will sit in the dental chair with the
child’s legs supported on their lap
2. The dental team will consist of the pediatric dentist
and a dental assistant; in the sedation session, there
will be a third person who is trained to monitor the
child, called the “observer”
3. Video recording: an action camera will be positioned
at the head of the operator to record the child’s face
and body up until the anesthetic procedure, and
another camera mounted on a tripod will record the
whole scenario during the entire dental appointment
4. The pediatric dentist will perform the dental
prophylaxis procedure at low speed in a front tooth
without caries. This procedure is proposed as a
baseline, non-painful dental stimulus, for the
comparison of the occurrence and intensity of pain
during dental treatment
5. The dentist will execute the anesthetic procedure
(topic and infiltrative)
6. The dentist will perform the dental restorative
procedure with composite or glass ionomer cement
Minute 20
Minute 13
Intranasally: Midazolam (Group A) or placebo (group B and C)
Minute 10
Intranasally: Ketamine (Group A) or placebo (Group B and Group C)
Minute 0
Orally: 
Placebo (Group A) or midazolam/ketamine (Group B) or midazolam (Group C)
Fig. 4 Sequence of sedative administration
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in one molar tooth after preparing the tooth with a
high speed handpiece, removing the caries using
excavators and under rubber dam isolation
7. At the end of the session, the dentist and the dental
assistant will assess the child’s behavior according to
the Frankl scale [22]
The pediatric dentists are trained in the application of
the Frankl scale [22], which classifies the child’s behavior
as follows: (1) Definitely negative – refusal of treatment;
intense crying, fear or any other evidence of extreme
negativism, (2) Negative – reluctance to accept treat-
ment; lack of cooperation; any other negative attitude,
(3) Positive – acceptance of treatment; willingness to co-
operate with the dentist despite some caution; followed
instructions from the dentist, (4) Definitely positive –
good behavior toward the dentist interested in dental
procedures; had fun with the situation.
The unsedated child will be scheduled for the next
phase of research (treatment under sedation) if they
present negative or definitely negative behavior accord-
ing to the Frankl scale [22]. In this case, the child’s par-
ent will receive preoperative guidelines which include
fasting instructions. On the other hand, if the unsedated
child displays positive or definitely positive behavior,
they will be referred for dental care using nonpharmaco-
logical approaches in the dental school.
Dental treatment will be aborted if the child presents
definitely negative behavior anytime during a given
session. Additionally, if any adverse event happens, the
dental treatment session will be interrupted or aborted,
depending on the seriousness of the episode [16]. Infor-
mation about positive or definitely negative behavior and
treatment being aborted will be recorded for further
analysis.
After the conclusion of the dental restoration in the se-
dated child, the observer will take the child and their par-
ent to the postanesthetic recovery room, where the parent
and dentist will independently answer questions about
their perception of the sedation success, the child’s pain
during the procedure, and their own stress during the pro-
cedure by answering three questions through a 10-cm
VAS: (1) How do you assess the child sedation? (2) How
much stress did you feel during treatment? (3) How much
pain do you think the child felt during treatment?
The child/parent will be discharged after fulfilling the
recommended criteria [18] and if additional dental pro-
cedures are required, they will be scheduled for treat-
ment at NESO.
Postoperative assessments
Twenty-four hours after dental restoration under sed-
ation, a member of the research team will call the child’s
parent to obtain information on adverse events and
memory. Mothers are asked to answer the following
questions: (1) Do you think your son/daughter remem-
bers the performed interventions? Why? and (2) Did
your son/daughter say something regarding the per-
formed interventions? If yes, what? These answers will
help to identify the sedative’s amnesic ability.
Intra and postoperative adverse events will be regis-
tered as recommended by the World SIVA International
Sedation Task Force as minimal, minor, and sentinel
risks [16]. The event report tool also allows for the regis-
tration of the interventions performed to treat the
adverse events, the outcome of the adverse events and,
finally, the assignment of an overall severity for the sed-
ation encounter.
One week after the dental restoration under sedation,
children older than 3 years will be asked about their
perceptions of the dental sedation by means of a semi-
structured interview. The researchers will conduct this
interview through an illustrated history called “Peppa
goes to the dentist.” In each history scenario, the child
will be asked questions related to their perceptions of
previous dental visits such as, “Did you go to the den-
tist? How do you feel waiting for the dentist? How do
you feel when you sit in a dental chair? Did you drink
any syrup in the dentist? How do you feel after drinking
this syrup? Did the dentist touch your mouth?” The
interviews are video recorded. After the interviews, they
are transcribed verbatim and analyzed by content ana-
lysis using the software NVivo (QSR International Pty
Ltd., Melbourne, VIC, Australia).
Saliva analysis
After collecting the saliva samples, the tubes will be cen-
trifuged at 3000 rpm for 15 min at the Immunohisto-
chemistry and Analysis of Saliva Laboratory. Until the
moment of its analysis, the saliva samples will be stored
frozen and coded to protect participant confidentially.
Laboratory analysis to measure cortisol in saliva samples
will be performed using an Enzyme Immunoassay Kit
(Salimetrics Kit, LLC, Carlsbad, CA, USA) for salivary
cortisol, following the information that came with the
same kit. A photometer reader (Perlong; DNM – 9602
Microplate Reader, Buena Park, CA, USA) at an absorb-
ance of 450 nm will be used for analysis of the cortisol
values obtained. Cortisol level is determined in accordance
with standard curves prepared according to the manufac-
turer (Salimetrics Kit, LLC, Carlsbad, CA, USA), with a
detection limit of 3000 μg/dL to 0.012 μg/dL.
Analyses of the video records
At the Qualitative Research Laboratory, observers (den-
tal undergraduate students) blinded to the intervention
will be trained and calibrated to assess children’s behav-
ior in the video files, according to the OSUBRS [13]
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score, using the software The Observer XT (Noldus, The
Netherlands), and the FLACC [14].
OSUBRS scores are 1 for quiet behavior, 2 for crying
without movement, 3 for movement without crying, and
4 for struggling. Observers will continuously assign
OSUBRS scores while watching the videos of the dental
treatment during the length of the procedure. The soft-
ware calculates the percentage for each score in a given
session.
Pain during administration of sedation and local
anesthesia will be assessed in videos by the FLACC,
which has five categories (Face, Legs, Activity, Cry,
Consolability) that are scored from 0 to 2 and result in a
total score of 10 [14]. Children will be observed for the
whole period of each phase of the administration of sed-
atives as well as during the administration of the dental
local anesthetic (local puncture for infiltrative anesthesia,
injection of anesthetic, and after removal of the carpule
syringe), and a score for each category will be assigned.
In addition, for comparison with potentially not painful
procedures, videos will be assessed for two other specific
periods: the start of the dental treatment and during the
prophylaxis procedure in a sound deciduous tooth.
One trained and calibrated observer will analyze each
video. The same observer will review one in five videos
again after 2 weeks to evaluate the intraobserver
agreement.
Economic analysis
The purpose of this analysis is to conduct a cost-
effectiveness analysis comparing the sedation regimes
for children during dental procedures, from the perspec-
tive of Brazil’s public health system. The primary out-
come will be the child’s behavior and adverse events
during and after sedative administration. The preopera-
tive procedures are inherent to all regimes, and their
costs will not be evaluated. The direct medical costs will
be taken into consideration. A decision tree will be de-
veloped using MS Excel (Microsoft, Redmond, WA,
USA) to estimate the costs and benefits associated with
the techniques. An incremental cost-effectiveness ratio
(ICER) will be carried out to classify the different strat-
egies [17, 26].
Outcome measures
The experimental, comparison and control groups will
be compared regarding one primary and several second-
ary outcomes. The main outcome is the child’s behavior
assessed according to the OSUBRS. Based on this
outcome, the dental sedation session will be considered
efficacious if the child’s behavior remains quiet
(OSUBRS score 1) for 60% or above of the session length
since the planned restorative treatment has been com-
pleted. The secondary outcomes are as follows:
1. Sedative administration acceptance: this outcome
will be assessed according to the child’s behavior
and pain. An OSUBRS score of 1 (quiet) for over
60% of the administration duration represents a
good acceptance (dichotomous variable, yes or no).
The presence or absence of pain and the pain
intensity are determined with the FLACC
2. Memory of intraoperative events: amnesia is
desirable and means that children do not recall the
figures/events after sedative administration
(dichotomous variable, yes or no), on the same day,
24 h or 1 week later
3. Salivary cortisol levels: children’s, parents’ and
dentists’ stress will be evaluated by salivary cortisol
levels, which are determined by the enzyme-linked
immunosorbent assay test as described elsewhere
[27] (continuous variable)
4. Adverse events: intra and postoperative adverse
events will be assessed through the World SIVA
Tool and categorized as minor, sentinel, and major
[16] but analyzed as yes/no for the purpose of this
study
5. Pain during treatment: the presence or absence of
pain and its intensity will be assessed through the
FLACC [14]
6. Caregivers’ and dentists’ perceptions of sedation: the
perceptions in the sedative groups will be compared
according to the answers in the Visual Analog Scale
(VAS) (continuous variable)
7. Child’s perception of dental sedation: this will be
assessed through content analysis of the transcripts
of a semistructured qualitative interview
8. Cost analysis: the cost of each sedation protocol
according to the methodology used will be analyzed
and compared across groups
Strategies to improve adherence to research
In order to maximize follow-up and adherence to the
study, the following strategies were adopted:
 During recruitment, the participants most likely to
join the study were selected. This was verified from
the attendance of the participants in the
consultations of clinical examination and dental
treatment without sedation. Individuals who did not
adhere to these queries, after three attempts to
schedule, were excluded
 By scheduling the patients, it was guaranteed that
the waiting time was short
 Responsible participants were provided with
reimbursement for travel
 In order to encourage those responsible to continue
with their children, the study emphasized the
importance of adherence and follow-up, as well as
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guidelines on oral health and referral for treatment
after research
Statistical analyses
Sample size planning
The estimated sample size was calculated based on the
primary outcome (child behavior during sedation). Before
starting the trial, we considered data from a previous
study [9] to estimate the sample size. In the study by
Moreira et al. (2013) [9], we found behavior scores
(measured using the OSUBRS) associated with the oral
administration of midazolam/ketamine (mean 8.6; stand-
ard deviation 4.1) and midazolam (mean 14.0; standard
deviation 3.8) and no sedative agent (mean 12.5; standard
deviation 5.2). Based on these values, 23 cases per group
would be required to obtain a power of 80% at the 5%
level.
We planned to conduct an interim analysis in April
2016 to monitor the data and to re-estimate the sample
size. Hereby, a blinded researcher ran the interim ana-
lysis including the first 30 cases. Accordingly, the three
groups presented efficacious sedation in 20%, 30%, and
60% of the cases, respectively, considering that, to be an
efficacious sedation, a child has to be quiet (OSUBRS
score 1) for at least 60% of the session length. Based on
the two extremes (20% and 60%), a total of 84 children,
or 28 children per group, are needed to fit the criteria
for a two-sided significance level of 5% and power of
80%, as calculated by the Fleiss continuity correction
method in the OpenEpi version 3. If we had considered
the other combinations of values observed in the interim
analysis, for example, 20% and 30%, we would need 325
children per group, which would be impracticable for
the conclusion of this study, since it would be more dif-
ficult to obtain a sample with the strict control of bias
(inclusion criteria, procedures, etc.) proposed.
The data needed to analyze the main outcome “child’s
behavior” is collected soon after the randomization of the
participant, which avoids the problems of loss to follow-
up. Similarly, the secondary variables “sedative administra-
tion acceptance,” “memory of intraoperative events on the
same day,” “salivary cortisol levels,” “intraoperative adverse
events,” “pain during treatment,” “caregivers’ and dentists’
perceptions of sedation,” and “cost-analysis” are collected
in the same visit. If the caregiver decides to withdraw con-
sent in this same visit and so incomplete data are obtained
for the abovementioned variables, the loss will be docu-
mented and the participant replaced to reach the final
sample of 84.
The collection of data allowing the analysis of the sec-
ondary outcomes “memory of intraoperative events 24 h
or 1 week later,” “postoperative adverse events” and
“child’s perception of dental sedation” need the compli-
ance of the child and caregiver during the follow-up as-
sessments. The participants will be encouraged to
continue in the trial through the attentive attitudes of
the committed research team (e.g., phone calls and mes-
sages), reimbursement of their research expenses (travel,
food, etc.) and by emphasizing their awareness of the
importance of the investigation. Nevertheless, if they do
not complete all secondary measurements, they will not
be replaced and their outcomes will be used in an
intention-to treat analyses.
Data analyses
The intervention will be concealed until after the statis-
tical analysis has been concluded. The data were typed in
duplicate and the statistical analysis was performed using
statistical software IBM SPSS 24.0 (IBM Corporation,
Armonk, NY, USA) and Prism software (GraphPad Prism
6; GraphPad Software, La Jolla, CA, USA), with a signifi-
cance level of 5%. Descriptive statistics will be provided,
overall and by study group. Additionally, bivariate analyses
will be performed. Each outcome, primary or secondary,
will be considered a dependent variable for distinct statis-
tical bivariate analyses that will be performed separately,
as detailed below and in Table 3. The independent vari-
ables will be: age, sex, dental history, child caries index,
length of visit with sedation and use of protective
stabilization during dental sedation, among others.
The chi-square test will verify the success of sedation
based on the child’s behavior (primary outcome) comparing
Table 3 Outcome variables and statistical tests
Variable Outcome measures Statistical test
Dichotomous Child’s behavior during the sedation appointment
and drug administration
Success of sedation
Sedative administration acceptance
Chi-square
Adverse events occurrence Intra and postoperative adverse events Chi-square
Pain during the sedation (intensity scores will be
described)
Sedative administration acceptance
Pain during treatment
Chi-square
Explicit memory Memory of intraoperative events Chi-square
Continuous Salivary cortisol levels Child’s, parent’s and dentists’ stress ANOVA or Kruskal-Wallis
Caregivers’ and dentists’ perception of sedation Caregivers’ and dentists’ perception of sedation ANOVA or Kruskal-Wallis
ANOVA analysis of variance
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the three groups. Child’s behavior will also be verified ac-
cording to age subgroups (2–3 years old and 4–6 years
old), also comparing the three groups. For the analysis of
secondary outcomes, statistical analysis of the variables that
need follow-up assessments will be carried out according to
the intention-to-treat principle, as explained before. For the
continuous variables, the Kolmogorov-Smirnov test will be
used to analyze the normality data, and then we will run
the analysis of variance (ANOVA) or Kruskal-Wallis tests.
A Data Monitoring Committee and external auditing are
not required by local standards, because this trial is small,
has a short duration and known risks.
Discussion
The conception of this protocol was based on the fol-
lowing two main goals: to determine a suitable sedative
regime for young children undergoing dental treatment
and to minimize the biases that have been identified in
this type of study, such as lack of a baseline measure-
ment of child’s anxiety and the use of supplemental ni-
trous oxide [8]. Additionally, we attempted to control
for the type of dental procedure to be performed and
limit the children’s age range, among other variables. In
addition, we will scrutinize the sedation success accord-
ing to multiple variables and not only the children’s be-
havior, occurrence of adverse events or completion of
the dental treatment. These major points deserve further
discussion henceforward.
The goal of the dental sedation for children of 1–6
years old is often solely to complete the treatment [8],
but our interest is to accomplish the procedure in the
most comfortable way [28]. This explains why we have
chosen several outcomes to assess the success of the
dental sedation. We had to select one primary outcome
that follows the majority of the RCTs on this topic,
namely, child behavior. However, we had to propose a
new way to assess successful child behavior in an at-
tempt to translate the results of this protocol to a better
practice and understanding of the conscious sedation
outcomes. Therefore, we chose a valid measure, the
OSUBRS, which has been shown to increase the chance
of more precise data than scales such as Houpt and
Venham for research purposes [29]. It is well known that
the lack of a standard behavior assessment scale for tri-
als on pediatric sedation makes it difficult to compare
studies [8], but the OSUBRS is one of the most widely
used behavior assessment scales for pediatric dental sed-
ation [29], which could favor pooling data in a system-
atic review. Based on continuous OSUBRS evaluation,
we considered that completion of the restorative dental
treatment (one tooth) with the child remaining quiet for
more than 60% of the duration of the session would rep-
resent a satisfactory outcome because they are young, in
the preoperational stage [30], and might not be able to
cooperate for the whole session even if sedated. There
are studies [8] that determine that sedation is successful
if it is possible to complete the treatment, regardless of
the children’s physical restraint, crying, and struggling.
We also included the occurrence of pain during the
drug administration and the dental sedation because
the ability to effectively control pain is a crucial as-
pect of pediatric dentistry. Additionally, we cannot
consider a sedative regime successful if it is related to
worrisome adverse events, which should be systemat-
ically assessed [16].
In addition, if we consider that conscious sedation
may not be successful in pediatric dentistry, we need to
know if children will remember if they cry/move/strug-
gle during the dental sedation to prevent the induction
of trauma. Our research team has developed a system-
atic review regarding the memory effects of sedative
drugs in children [31]; scientific evidence regarding this
issue is necessary.
We have already found in a crossover trial (oral mid-
azolam versus placebo, n = 18) that a child’s physio-
logical stress response during a sedation appointment,
as assessed by salivary cortisol, is not associated with
the child’s behavior [27]. Thus, in this RCT, we have
planned to verify the cortisol levels in a different study de-
sign – parallel, larger sample size, midazolam-ketamine
combination, and the oral versus the intranasal route.
In a crossover design, it is alleged that the second
treatment phase depends on the success of the first
treatment period [8].
Another point to be assessed in a potentially successful
sedation is the perspective of the people involved –
child, parent, and dentist. “Outcome variables need to be
more patient-centered” [8]. Therefore, we are investigat-
ing the perceptions of the child on the dental sedation
session 1 week later as well as the views from the parent
who stayed with the child during the procedure and the
pediatric dentist who conducted the procedure (quanti-
tative approach). In a qualitative approach, we have
already identified that mothers from children sedated for
dental treatment self-report stress related to the proced-
ure but are satisfied with this pharmacological method
of behavior management [32]. Nevertheless, we have not
found a RCT on pediatric dental sedation that examines
the children’s view of the procedure.
The other secondary outcome that will allow for a
comparison between groups is the sedation costs. It is
very important to analyze sedation costs, especially
considering public health policies, and these have not
received enough attention in pediatric dentistry. In the
pediatric ophthalmology field, for example, a cost-
effectiveness analysis of clinic-based chloral hydrate sed-
ation versus general anesthesia demonstrated significant
savings with sedation but with slightly fewer procedures
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completed [33]. A systematic review updated in 2015
[34] found no eligible study to compare the morbidity
and cost of general anesthesia and sedation for dental
treatment in children younger than 18 years.
To participate in this study, children have to present a
negative/definitely negative behavior [22] during the
dental examination or in a preliminary session in which
restorative treatment is performed without sedation. The
rationale for this is to avoid including children with
positive behavior who were referred for dental treatment
under sedation by a dentist who was not able to guide
the children’s behavior properly. However, as included
children have negative behavior and early childhood car-
ies and many of them require numerous dental proce-
dures, general anesthesia rather than sedation may be
the best indication for them. Therefore, one limitation of
the present RCT protocol is that we are, in some ways,
pushing the limits of sedation indication, although we
have restricted the age group involved.
The experimental group will receive a combination of
intranasally administered ketamine and midazolam. In
fact, intranasal administration of ketamine combined
with midazolam has demonstrated a high success rate
for child behavior management during dental treatment
[11]. However, that study had a crossover design, and
the use of an atomizer is not reported, which may inter-
fere with the effect of the sedatives. Additionally, the
proposal to first administer ketamine to potentially
provide analgesia and minimize the pain associated with
intranasally administered midazolam is innovative, as
the analgesic effect of intranasally administered keta-
mine begins as early as 3 min after administration [35].
We chose oral administration of midazolam alone for
the control group because it has been shown to improve
children’s behavior compared to placebo, according to
five heterogeneous studies included in a systematic re-
view, which is the best evidence for a pediatric dental
sedation drug, although weak [8].
Blinding is another crucial point for assessing sedation
outcomes [8], and we were able to mask the patient/par-
ent, the dental team and the observers to the intervention
groups. To achieve that, we have to provide placebos for
the sedative route of administration (intranasal and oral)
so that all children receive some substance through the
nose and mouth. Furthermore, we planned the same
sequence of administration for all groups. Additionally, we
will videotape the administration of the drugs and the
entire dental procedure so that trained and calibrated ob-
servers who are not in the dental sedation office can assess
the primary outcome. As far as we know, this rigorous
masking has not been consistently provided in other RCTs
on pediatric dental sedation [8, 36–38]. The video record-
ing of the sedative administration and dental procedures
is also original. We propose an action camera adapted for
the operator’s head to allow for a close view of the facial
expressions of the children, and then, a valid pain assess-
ment through the FLACC [14, 39, 40], which is validated
for use with Brazilian children [14].
All in all, this study protocol has strengths that will
allow for better analysis of pediatric dental sedation,
with a potential impact on health practice and public
and private service. Because there is no new medication
for sedation in the pipeline, efforts to define a best pos-
sible route of administration and combination of drugs
is a real need. In addition, the degree of stimulation ex-
perienced by patients in the pediatric dental setting
makes it a special challenge. This study emphasizes a
new and promising protocol in pediatric dentistry com-
bining a feasible route (intranasal) and synergistic drugs.
Trial status
This RCT began in June 2015 and the process of recruit-
ment is still ongoing.
Additional files
Additional file 1: World Health Organization Trial Registration Data Set.
(PDF 80 kb)
Additional file 2: Consent Forms applied to parents and pediatric
dentists (in Portuguese). (PDF 185 kb)
Additional file 3: SPIRIT 2013 Checklist for the NASO study protocol.
(DOC 104 kb)
Abbreviations
ASA: American Society of Anesthesiologists; FLACC: Face, Legs, Activity, Cry,
Consolability Pain Assessment Tool; FO: Faculdade de Odontologia;
ICER: Incremental cost-effectiveness ratio; NASO: The short form to
denominate this investigation (derived from “intranasal”); NESO: Núcleo de
Estudos em Sedação Odontológica; OSUBRS: Ohio State University Behavioral
Rating Scale; RCT(s): Randomized controlled trial(s); SPIRIT: Standard Protocol
Items: Recommendations for Interventional Trials; UFG: Universidade Federal
de Goiás; VAS: Visual Analogue Scale
Acknowledgements
We thank Anna Alice Anabuki, Kárita Cristina Silva, Mônica Maia Moterante,
Nayara Rúbia de Araújo, Vinícius Braudes Martins Rodrigues, and Vitória
Oliveira Magalhães for helping with the study development.
Funding
Three Brazilian funding agencies have provided scholarships for professors
and graduate students to do research, including the one reported herein:
the National Council for Scientific and Technological Development (CNPq,
Brazil), the Coordination for the Improvement of Higher Education Personnel
(CAPES, Brazil), and the State of Goiás Research Foundation (FAPEG, Brazil).
Moreover, this specific project received two grants from the CNPq: the first,
for the acquisition of material and the temporary hiring of a research
assistant for the development of the study (449950/2014-0); the second, a
research individual scholarship to LRC (305315/2015-3). These funding
agencies did not interfere in any stage of the preparation of this protocol
and this manuscript.
Availability of data and materials
The datasets generated by the current study protocol will be available from
the corresponding author on reasonable request.
Gomes et al. Trials  (2017) 18:172 Page 12 of 14
Authors’ contributions
The role of authors and contributors was defined according to the
International Committee of Medical Journal Editors [41]. HSG contributed to
the overall conceptualization of the study and study design, with focus on
the stress outcome, and drafted this manuscript. ARM helped with the pain
assessment design and drafted this manuscript. KAV contributed to the
design of this study, focusing on the memory outcome, and critically revised
this manuscript. ACB contributed to the conceptualization of the study and
study design and revised the manuscript during its preparation. PSC was
responsible for the study conceptualization and design and critically revised
the manuscript. AD helped with the study conception, the pain assessment
design and statistical plan, and critically revised the manuscript. GCMM
helped with the overall conceptualization of the study, focusing on the
participants’ and dentists’ perspective outcome, and critically revised the
manuscript. JSF helped with the study design, mainly the intervention
groups and the behavior assessment outcome, and critically revised the
manuscript. LACV helped with the study design for the economic analysis
and critically revised the manuscript. PCF helped with the overall
conceptualization of the study and critically revised the manuscript. MTH
provided a substantial contribution to the study design and critically edited
and revised the final draft of this manuscript. LRC conceived the study,
established the statistical planning, markedly revised the manuscript and
coordinates the research team. All authors read and approved the final
version of the manuscript and agree to be accountable for all aspects of the
work in ensuring that questions related to the accuracy or integrity of any
part of the work are appropriately investigated and resolved.
Authors’ information
HSG, ARM, AD, GCMM, LACV, MTH, and LRC are certified pediatric dentists and
have in-depth understanding of the subject of child behavior management.
PSC is a pediatrician with knowledge of outpatient sedation. JSF is an
anesthesiologist. HSG and ACB have expertise in salivary cortisol analysis. KAV
have done a systematic review on memory related to sedation in health
procedures. HSG, ACB, PSC, MTH, and LRC have prior experience in conducting
RCTs. AD, PCF, and LRC have skills in statistical analyses. PSC, MTH, and LRC are
members of the International Committee for the Advancement of Procedural
Sedation (ICAPS – http://proceduralsedation.org).
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Ethical approval was granted by the Research Ethics Committee of the
Universidade Federal de Goiás (UFG), Brazil (protocol #857.066, 12 November
2014), and informed consent will be sought from the parents of the children.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Dentistry Graduate Program, Faculdade de Odontologia (FO), Universidade
Federal de Goiás (UFG), Goiânia, GO 74605-220, Brazil. 2Department of
Stomatology (Oral Pathology), FO/UFG, Goiânia, GO 74605-220, Brazil.
3Department of Pediatrics, Faculdade de Medicina (FM), UFG, Goiânia, GO
74605-020, Brazil. 4Health Sciences Graduate Program, FM/UFG, Goiânia, GO
74605-020, Brazil. 5Department of Oral Health, FO/UFG, Goiânia, GO
74605-220, Brazil. 6Pediatric Dentistry, Division of Population and Patient
Health, King’s College London Dental Institute, Bessemer Road, London SE5
9RS, UK. 7Faculdade de Odontologia, Universidade Federal de Goiás, Primeira
Avenida, Setor Universitário, CEP: 74605-220 Goiânia, Goiás, Brazil.
Received: 21 October 2016 Accepted: 29 March 2017
References
1. Arnrup K, Broberg AG, Berggren U, Bodin L. Temperamental reactivity and
negative emotionality in uncooperative children referred to specialized
paediatric dentistry compared to children in ordinary dental care.
Int J Paediatr Dent. 2007;17(6):419–29.
2. Klaassen MA, Veerkamp JS, Hoogstraten J. Dental fear, communication, and
behavioural management problems in children referred for dental
problems. Int J Paediatr Dent. 2007;17(6):469–77.
3. Taskinen H, Kankaala T, Rajavaara P, Pesonen P, Laitala ML, Anttonen V. Self-
reported causes for referral to dental treatment under general anaesthesia
(DGA): a cross-sectional survey. Eur Arch Paediatr Dent. 2014;15(2):105–12.
4. Elledge R, Alexopoulos E, Hosey MT. Short communication: dental anxiety
levels and outcomes of care: a preliminary report on experiences of a
sedation assessment clinic. Eur Arch Paediatr Dent. 2007;8(4):211–4.
5. Boyle CA, Newton T, Milgrom P. Who is referred for sedation for dentistry
and why? Br Dent J. 2009;206(6):E12. discussion 322-3.
6. Olley RC, Hosey MT, Renton T, Gallagher J. Why are children still having
preventable extractions under general anaesthetic? A service evaluation of
the views of parents of a high caries risk group of children. Br Dent J. 2011;
2010(8):1–8.
7. American Academy on Pediatric Dentistry Clinical Affairs Committee-
Behavior Management Subcommittee. Guideline on behavior guidance for
the pediatric dental patient. Pediatr Dent. 2015-2016;37(6):180–93. http://
www.aapd.org/media/policies_guidelines/g_behavguide.pdf. Accessed on
25 May 2016.
8. Lourenço-Matharu L, Ashley PF, Furness S. Sedation of children undergoing
dental treatment. Cochrane Database Syst Rev. 2012;3:CD003877.
9. Moreira TA, Costa PS, Costa LR, Jesus-França CM, Antunes DE, Gomes HS, et
al. Combined oral midazolam-ketamine better than midazolam alone for
sedation of young children: a randomized controlled trial. Int J Paediatr
Dent. 2013;23(3):207–15.
10. Wolfe TR, Braude DA. Intranasal medication delivery for children: a brief
review and update. Pediatrics. 2010;126(3):532–7.
11. Bahetwar SK, Pandey RK, Saksena AK, Chandra G. A comparative evaluation
of intranasal midazolam, ketamine and their combination for sedation of
young uncooperative pediatric dental patients: a triple blind randomized
crossover trial. J Clin Pediatr Dent. 2011;35(4):415–20.
12. Buonsenso D, Barone G, Valentini P, Pierri F, Riccardi R, Chiaretti A. Utility of
intranasal ketamine and midazolam to perform gastric aspirates in children: a
double-blind, placebo controlled, randomized study. BMC Pediatr. 2014;14:67.
13. Lochary ME, Wilson S, Griffen AL, Coury DL. Temperament as a predictor of
behavior for conscious sedation in dentistry. Pediatric Dent. 1993;15(5):348–52.
14. Silva FC, Thuler LC. Cross-cultural adaptation and translation of two pain
assessment tools in children and adolescents. J Pediatr (Rio J). 2008;84(4):344–9.
15. Ghoneim MM. Drugs and human memory (part 1): clinical, theoretical, and
methodologic issues. Anesthesiology. 2004;100(4):987–1002.
16. Mason KP, Green SM, Piacevoli Q, International Sedation Task Force. Adverse
event reporting tool to standardize the reporting and tracking of adverse
events during procedural sedation: a consensus document from the World
SIVA International Sedation Task Force. Br J Anaesth. 2012;108(1):13–20.
17. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL.
Methods for the economic evaluation of health care programmes. 3rd ed.
New York: Oxford University Press; 2005.
18. American Academy of Pediatrics; American Academy of Pediatric Dentistry.
Guideline for monitoring and management of pediatric patients during and
after sedation for diagnostic and therapeutic procedures. Pediatr Dent.
2015-2016-16;37(6):211–27. Available at: http://www.aapd.org/media/
policies_guidelines/g_sedation.pdf. Accessed on 25 May 2016.
19. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et
al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials.
Ann Intern Med. 2013;158:200–7.
20. American Society of Anesthesiologists. ASA Physical Status Classification
System. Available at: https://www.asahq.org/resources/clinical-information/
asa-physical-status-classification-system. Accessed on 25 May 2016.
21. Mallampati SR, Gatt SP, Gugino LD, Desai SP, Waraska B, Freiberger D, et al.
A clinical sign to predict difficult tracheal intubation: a prospective study.
Can Anaesth Soc J. 1985;32(4):429–34.
Gomes et al. Trials  (2017) 18:172 Page 13 of 14
22. Frankl S, Shiere F, Fogels H. Should the parent remain with the child in the
dental operatory. J Dent Child. 1962;29:150–63.
23. WHO. World Health Organization. Oral health surveys: basic methods. 5th
ed. Geneva: World Health Organization; 2013.
24. Ali N, Pruessner JC. The salivary alpha amylase over cortisol ratio as a
marker to assess dysregulations of the stress systems. Physiol Behav.
2012;106(1):65–72.
25. Singh C, Pandey RK, Saksena AK, Chandra G. A comparative evaluation of
analgo-sedative effects of oral dexmedetomidine and ketamine: a triple-
blind, randomized study. Paediatr Anaesth. 2014;24(12):1252–9.
26. Brasil. Ministério da Saúde. Secretaria-Executiva. Área de Economia da Saúde e
Desenvolvimento. Avaliação de tecnologias em saúde: ferramentas para a
gestão do SUS / Ministério da Saúde, Secretaria-Executiva, Área de Economia
da Saúde e Desenvolvimento. – Brasília: Ministério da Saúde, 2009.
27. Gomes HS, Corrêa-Faria P, Silva TA, Paiva SM, Costa PS, Batista AC, et al. Oral
midazolam reduces cortisol levels during local anaesthesia in children: a
randomised controlled trial. Braz Oral Res. 2015;29(1):1–9.
28. Leroy PL, Costa LR, Emmanouil D, van Beukering A, Franck LS. Beyond the
drugs: nonpharmacologic strategies to optimize procedural care in children.
Curr Opin Anaesthesiol. 2016;29 Suppl 1:S1–13.
29. Moura LD, Costa PS, Costa LR. How do observational scales correlate the
ratings of children’s behavior during pediatric procedural sedation? Biomed
Res Int. 2016;2016:5248271.
30. Feigal RJ. Guiding and managing the child dental patient: a fresh look at
old pedagogy. J Dent Educ. 2001;65:1369–77.
31. Viana KA, Daher A, Maia LC, Costa PS, Martins CC, Paiva SM, et al. Memory
effects of sedative drugs in children and adolescents-protocol for a
systematic review. Syst Rev. 2016;5(1):34.
32. Lima ARA, Medeiros M, Costa LR. Mothers’ perception about pediatric
dental sedation as an alternative to dental general anesthesia. RGO. Rev
Gauch Odontol. 2015;63(2):153–60.
33. Burnett HF, Lambley R, West SK, Ungar WJ, Mireskandari K. Cost-
effectiveness analysis of clinic-based choral hydrate sedation versus general
anaesthesia for paediatric ophtalmological procedures. Br J Ophthalmol.
2015;99(11):1565–70.
34. Ashley PF, Williams CE, Moles DR, Parry J. Sedation versus general
anaesthesia for provision of dental treatment to patients younger than
18 years. Cochrane Database Syst Rev. 2015;9:CD006334.
35. Johansson J, Sjöberg J, Nordgren M, Sandström E, Sjöberg F, Zetterström H.
Prehospital analgesia using nasal administration of S-ketamine—a case
series. Scand J Trauma Resusc Emerg Med. 2013;21:38.
36. Shanmugaavel AK, Asokan S, Baby JJ, Priya G, Gnana DJ. Comparison of
behavior and dental anxiety during intranasal and sublingual midazolam
sedation—a randomized controlled trial. J Clin Pediatr Dent. 2016;40(1):81–7.
37. Sunbul N, Delvi MB, Zahrani TA, Salama F. Buccal versus intranasal midazolam
sedation for pediatric dental patients. Pediatr Dent. 2014;36(7):483–8.
38. Tyagi P, Tyagi S, Jain A. Sedative effects of oral midazolam, intravenous
midazolam and oral diazepam in the dental treatment of children.
J Clin Pediatr Dent. 2013;37(3):301–5.
39. Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S. The FLACC: a behavioral
scale for scoring postoperative pain in young children. Pediatr Nurs. 1997;
23(3):293–7.
40. Crellin DJ, Harrison D, Santamaria N, Babl FE. Systematic review of the Face,
Legs, Activity, Cry and Consolability Scale for assessing pain in infants and
children: is it reliable, valid, and feasible for use? Pain. 2015;156(11):2132–51.
41. International Committee of Medical Journal Editors. Defining the role of
authors and contributors. Available in: http://www.icmje.org/
recommendations/browse/roles-and-responsibilities/defining-the-role-of-
authors-and-contributors.html. Accessed on 18 March 2017.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Gomes et al. Trials  (2017) 18:172 Page 14 of 14
